Source comparison
Best Tesamorelin Dosage Body Composition 2026: Protocol Comparison
The table below compares tesamorelin dosing protocols based on clinical trial data, practical administration factors, and VAT reduction outcomes. Standard Clinical 2mg SC daily Evening (8-10 PM) 15-18% mean reduction 22-28% (injection site reactions, arthralgi
This comparison does not assign a generated winner or score.
- The table below compares tesamorelin dosing protocols based on clinical trial data, practical administration factors, and VAT reduction outcomes.
- Standard Clinical
- 2mg SC daily
- Evening (8-10 PM)
- 15-18% mean reduction
- 22-28% (injection site reactions, arthralgias)
- Gold standard protocol. Aligns with endogenous GH pulse timing and maximizes lipolytic signaling without exceeding receptor saturation threshold
- Low-Dose Titration
- 1mg daily weeks 1-2, then 2mg
- Evening
- 12-14% mean reduction
- 18-22%
- Reduced initial side effects but delays onset of VAT reduction by 3-4 weeks. Only justified in patients with history of GH intolerance
- High-Dose Experimental
- 3mg SC daily
- 16-19% mean reduction
- 38-45%
- No meaningful efficacy gain over 2mg but significantly higher rates of peripheral edema and carpal tunnel symptoms. Not recommended
- Split-Dose
- 1mg twice daily (morning + evening)
- 8 AM and 8 PM
- 10-13% mean reduction
- 25-30%
- Inferior to single daily dosing. Disrupts physiological GH pulse architecture and reduces peak amplitude, limiting VAT lipolysis
- Intermittent (5 days on, 2 days off)
- 2mg on active days
- Evening on active days
- 9-11% mean reduction
- 20-24%
- Cost-saving strategy that sacrifices 40% of efficacy. GH receptor signaling requires daily stimulation to sustain ATGL upregulation